Scientists discover world's rarest blood group, found in just one person
The sole known carrier is a woman from Guadeloupe whose blood is so unique that doctors couldn't find a single compatible donor.
The discovery of the 48th recognised blood group, called 'Gwada-negative', began when the woman's blood plasma reacted against every potential donor sample tested, including those from her own siblings. Consequently, it was impossible to find a suitable blood donor for her.
Most people know their blood type – A, B, AB or O – along with whether they are Rh-positive or negative. But these familiar categories (those letters plus 'positive' or 'negative') represent just two of several dozens of blood group systems that determine compatibility for transfusions.
Each system reflects subtle but crucial differences in the proteins and sugars coating our red blood cells.
To solve the mystery of the Guadeloupian woman's incompatible blood, scientists turned to cutting-edge genetic analysis. Using whole exome sequencing – a technique that examines all 20,000-plus human genes – they discovered a mutation in a gene called PIGZ.
This gene produces an enzyme responsible for adding a specific sugar to an important molecule on cell membranes. The missing sugar changes the structure of a molecule on the surface of red blood cells.
This change creates a new antigen – a key feature that defines a blood group – resulting in an entirely new classification: Gwada-positive (having the antigen) or -negative (lacking it).
Using gene editing technology, the team confirmed their discovery by recreating the mutation in a lab. So red blood cells from all blood donors tested are Gwada-positive and the Guadeloupean patient is the only known Gwada-negative person on the planet.
The implications of the discovery extend beyond blood transfusions. The patient suffers from mild intellectual disability, and tragically, she lost two babies at birth – outcomes that may be connected to her rare genetic mutation.
The enzyme produced by the PIGZ gene operates at the final stage of building a complex molecule called GPI (glycosylphosphatidylinositol).
Previous research has shown that people with defects in other enzymes needed for GPI assembly can experience neurological problems ranging from developmental delays to seizures. Stillbirths are also common among women with these inherited disorders.
Although the Caribbean patient is the only person in the world so far with this rare blood type, neurological conditions including developmental delay, intellectual disability and seizures have been noted in other people with defects in enzymes needed earlier in the GPI assembly line.
The Gwada discovery highlights both the marvels and challenges of human genetic diversity. Blood groups evolved partly as protection against infectious diseases (many bacteria, viruses and parasites use blood group molecules as entry points into cells). This means your blood type can influence your susceptibility to certain diseases.
But extreme rarity creates medical dilemmas. The French researchers acknowledge they cannot predict what would happen if Gwada-incompatible blood were transfused into the Guadeloupian woman. Even if other Gwada-negative people exist, they would be extremely difficult to locate. It is also unclear if they can become blood donors.
This reality points towards a futuristic solution: lab-grown blood cells. Scientists are already working on growing red blood cells from stem cells that could be genetically modified to match ultra-rare blood types. In the case of Gwada, researchers could artificially create Gwada-negative red blood cells by mutating the PIGZ gene.
A growing field
Gwada joins 47 other blood group systems recognised by the International Society of Blood Transfusion. Like most of these blood-group systems, it was discovered in a hospital lab where technicians were trying to find compatible blood for a patient.
The name reflects the case's Caribbean roots: Gwada is slang for someone from Guadeloupe, giving this blood group both scientific relevance and cultural resonance.
As genetic sequencing becomes more advanced and widely used, researchers expect to uncover more rare blood types. Each discovery expands our understanding of human variation and raises fresh challenges for transfusion and other types of personalised medicine.
Martin L. Olsson is a Medical Director at the Nordic Reference Laboratory for Blood Group Genomics, Region Skåne & Professor of Transfusion Medicine, Head of the Division, Lund University
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
2 hours ago
- The Independent
What is chikungunya? How to avoid debilitating virus while on holiday as cases rise in France
Health officials are warning travellers of a mosquito-borne virus that can cause debilitating joint pain, after cases emerged in areas of France. While the virus known as chikungunya is more commonly found in tropical areas of the world, cases have now been appeared in France, a popular holiday destination for Brits, especially during the summer months. This year so far, France has reported 14 cases of chikungunya virus, on the mainland and the French island of Corsica. While Europe is not currently experiencing a severe outbreak, health officials on the continent are making travellers aware of the virus as well as the rollout of a new vaccine in the UK. We have rounded up what travellers need to know about the virus, plus advice from a specialist travel doctor on how to best prepare for travelling overseas. What is chikungunya and how is it spread? Chikungunya virus disease is a mosquito-borne disease that is found across tropical and sub-tropical regions. It is spread to humans by a bite from an infected mosquito. It cannot be passed from human to human. Most cases have been found in the Americas, Africa and Asia. Brazil has the most cases, with over 141,000, followed by Argentina with over 2,500 so far in 2025. In total, there have been approximately 220,000 chikungunya cases and 80 related deaths across 14 countries/territories since the beginning of the year. Réunion and Mayotte, two French islands off the east coast of Africa, have ongoing outbreaks of chikungunya, with the former recording 51,000 cases as of May 2025. Mayotte has seen 560 cases, with the island moved to the epidemic phase, which indicates intense and widespread transmission of the virus throughout the territory. The transmission of dengue and chikungunya virus in mainland Europe has been linked by the European Centre for Disease Prevention and Control (ECDC) to travellers who have caught the virus outside the region, then gone to countries within Europe with mosquitoes that are able to carry the virus after biting the person. 'The risk of locally acquired chikungunya and dengue virus transmissions is therefore increasing,' the ECDC said. What are the symptoms? 'Chikungunya' comes from a word used by the Makonde people in Tanzania, where the disease was first discovered in the 1950s, which means 'that which bends up'. This describes the contorted posture of infected people who experience severe joint pain. Alongside joint pain, people can also experience an abrupt onset of fever, joint swelling, muscle pain, headaches, nausea, fatigue and rashes. The joint pain can be debilitating and usually lasts for a few days, but it has been known to last for weeks, months or even years. If an infected person does not experience joint pain, the symptoms will be mild and can go unrecognised as chikungunya. Most people will recover fully from the infection. There have been some occasional cases of eye, heart, and neurological complications, while newborns and older people with underlying medical conditions are at a higher risk of severe disease. Patients with severe disease should be hospitalised because of the risk of organ damage or death. Once someone has recovered from chikungunya, they are likely to be immune to future chikungunya infections. Is there a vaccine? The UK government has approved a vaccine against chikungunya disease, containing a form of the virus that has been weakened so it cannot multiply. The vaccine works by training the immune system to recognise the virus, which will then produce specific antibodies to attack it. It can only be obtained via a prescription and given to those who plan to travel abroad where the virus is present. Last month, the government released a further announcement to say that the Commission on Human Medicines has temporarily restricted the use of the vaccine in people aged 65 and over as a precautionary measure. To prevent getting bitten by mosquitoes, the World Health Organisation advises using insecticides; wearing clothing that minimises skin exposure; using window and door screens, and insecticide-treated mosquito nets; and applying certain repellants to skin and clothing. A travel doctor's guide on being prepared Dr Richard Dawood, a travel medical specialist at Fleet Street Clinic, explained to The Independent how the vaccination can help travellers prevent getting sick from the chikungunya virus. He said: 'This is a new situation for us. Until a very short time ago, we had no vaccine, and the only approach to prevention was to make careful use of insect repellents and insect precautions. 'So now we've got this extra tool in the armoury, and because the vaccine gives long-lasting protection, it's something that could be considered if you are planning to travel over a period of time. 'It's a fairly expensive vaccine, but if you're going to be travelling over a period of years to Southern Europe and beyond, it may be something that could be considered.' When asked about getting the vaccination for a trip to France, Mr Dawood advised to look at the decision in terms of where you will be travelling over the next few years rather than in the context of a single trip. 'The risk from a one-off short trip to France is probably very small,' he said. 'There's been only a very small number of cases so far. So statistically, you're not very likely to, but over time, as somebody who loves to travel and loves going to hot countries, then I would probably want to be protected against it in the long term.' Wherever you are travelling, Mr Dawood advised holidaymakers to 'do your homework'. He said: 'If there's an actual outbreak at your destination, then I would say no hesitation, definitely have the vaccine. 'Taking a bit of time and getting some really focused travel health advice for your particular trip is very worthwhile because it can save you from getting a vaccine that you don't need or that may not be sensible for you, and it can help prioritise the really important things for your trip.
Daily Mail
4 hours ago
- Daily Mail
Beware! Why your holiday insurance could be at risk if you're on weight-loss jabs
Half a million people using weight-loss jabs are at risk of invalidating their travel insurance this summer, experts warn. Drugs such as Mounjaro and Wegovy have soared in popularity since their approval by the NHS to help tackle diabetes and obesity.
Daily Mail
9 hours ago
- Daily Mail
Scientists reveal exactly what a neanderthal human hybrid would look like
It has been over 40,000 years since the last of the Neanderthals, our ancient human cousins, disappeared from the Earth. But from the shape of your nose to whether someone is an early riser, Neanderthal genes are still shaping many of our lives today. Starting from around 250,000 years ago, ancient homo sapiens and Neanderthals met, lived alongside each other, and often had children together. Now, MailOnline has asked leading paleoanthropologists to reveal what those hybrid children would have looked like. Scientists believe that hybrid children would inherit traits from both of their parents. That means hybrids might have a Neanderthal's long arms and short legs with the smaller skull of a Homo sapiens. Likewise, some of the hybrid children may have had strong Neanderthal facial features but the upright posture and long legs of a modern human. In some cases, this hybridisation process could even lead to the formation of unusual, new traits, not found in either parent. What would a hybrid look like? In a new research paper published this month, scientists revealed that a 5-year-old girl who lived 140,000 years ago was likely a Neanderthal-Homo sapiens hybrid. The girl's skull had been found in the Skhul Cave on Mount Carmel, Israel, in 1929 in the earliest known human cemetery alongside seven adults, two other children, and the bones of 16 other hominins. Originally, anthropologists classified the girl and all the bodies in the cemetery as Homo sapiens. However, when researchers re-examined the skull with CT scanning, they found that it had a mixture of both neanderthal and homo sapiens traits. Anne Dambricourt-Malassé, a paleoanthropologist at the French National Centre for Scientific Research and co-author of the study, told MailOnline that this girl's skeleton tells us what hybrids might have looked like. Dr Dambricourt-Malassé says that the girl had 'a powerful neck, a little higher than Homo sapiens, her forehead was less bulging.' The girl also showed a 'slight subnasal prognathism', meaning that her jaw would have jutted out much like the famous 'Habsburg chin'. 'Her smile showed a dental arch with the canines and incisors aligned and end-to-end, the upper and lower teeth touched,' says Dr Dambricourt-Malassé. Her spine shows that she would have had a more upright position than a Neanderthal, who typically walked with a curved back. However, the girl's jaw, spine, and pelvis all bear features that appear to be more Neanderthal in their origin. Overall, the girl might not look radically different to a modern human, but there would be noticeable differences in their features. New facial features In addition to having a mixture of traits from both parents, some researchers believe that interbreeding might have given rise to entirely new characteristics. In animals, hybrids often pick up new features that aren't present in either parent. For example, hybrids between Russian and Chinese mice often have huge heads, while coyote-wolf hybrids grow strange extra teeth or unusual 'gaps' in their bones. Likewise, Professor Israel Hershkovitz, an anthropologist from Tel Aviv University and a leading expert on human interbreeding, told MailOnline that this happens with humans as well. Professor Hershkovitz says: 'A good example is the bony ridge above the orbits [the eye socket], which is unique to the Skhul people.' This was 'not rounded but straight and continuous, protruding forward like a visor.' What would a hybrid look like after multiple generations? The so-called 'Skhul 1 Child' is extremely rare because Dr Dambricourt-Malassé and her co-authors believe she is the direct offspring of a Neanderthal and Homo sapiens. However, most examples of interbreeding show evidence of a gradual mixing over a much longer period of time. Professor Hershkovitz says: 'You have to distinguish between first-generation hybrid and long-running process. In the first case, Professor Hershkovitz says the hybrid will look much like their father or mother, with a few traits from the other parent. Hybrids formed over potentially thousands of years of inbreeding, meanwhile, will 'generally possess the shape of either the Neanderthal or Homo sapiens but will still show some traits of the other population.' According to many researchers, this is why we find examples of hybrids that exhibit a mosaic of traits from both human species. These hybrids would usually have some mixture of traits from both lineages. João Zilhão, a paleoanthropologist at the University of Barcelona, told MailOnline: 'Based on the fossils we have, in some cases it was body proportions, in other cases it was the morphology of bones in the cranium, in other cases it was the shape of the mandible, in still others the shape or the tissue composition of the dentition [teeth]. One example of such a hybrid is the 'Lapedo child', whose remains were found in Portugal's Lapedo valley in 1998. The child's heavy limbs and stocky build resembled those of a Neanderthal, but their chin and other features were unmistakably from Homo sapiens. Using novel dating methods, subsequent research has shown that this child probably died sometime between 27,780 and 28,550 years ago. This was extremely unusual since Neanderthals were supposed to have died out 40,000 years ago. That means this hybrid population was keeping Homo sapiens and Neanderthal genes alive over 10,000 years after the last 'pure' Neanderthals had vanished. Two separate species? According to Dr Zilhão, a co-author on the study, this shows that the two species must have been interbreeding far more frequently than most scientists were ready to consider. Dr Zilhão says: 'All the genetically 'modern' specimens from the time of contact that have been genomically sequenced have been shown to have 'pure' Neandertals in their family history dating back no more than four to six generations. 'At least 45 per cent of the specifically 'Neandertal' part of the Neandertals' genome is still found among present-day humans. 'You can compute yourself what the odds are that such facts can be explained other than by interbreeding being the rule rather than the exception.' Scientists believe that Homo sapiens and Neanderthals had two major periods of overlap and interbreeding. The first occurred around 250,000 years ago in what is now the modern-day Levant and lasted nearly 200,000 years. Followed by a second, shorter period of overlap of a few thousand years from about 45,000 years ago when Homo sapiens arrived in Europe. Over that time, some scientists think that the two species became extremely interconnected. Professor Hershkovitz believes that in the Levant, there were no 'pure' populations, only a population that looked like Neanderthals but had some Homo sapiens genes and a population that looked like Homo sapiens but retained some Neanderthal genes. Perhaps more controversially, Dr Zilhão and a few other scientists now argue that Homo sapiens and Neanderthals were not really distinct species all along. Dr Zilhão says: 'This shows that Neanderthals were Homo sapiens too. They were a West Eurasian variety, or race if you wish, of Homo sapiens.' A close relative of modern humans, Neanderthals went extinct 40,000 years ago The Neanderthals were a close human ancestor that mysteriously died out around 40,000 years ago. The species lived in Africa with early humans for millennia before moving across to Europe around 300,000 years ago. They were later joined by humans, who entered Eurasia around 48,000 years ago. These were the original 'cavemen', historically thought to be dim-witted and brutish compared to modern humans. In recent years though, and especially over the last decade, it has become increasingly apparent we've been selling Neanderthals short. A growing body of evidence points to a more sophisticated and multi-talented kind of 'caveman' than anyone thought possible. It now seems likely that Neanderthals had told, buried their dead, painted and even interbred with humans. They used body art such as pigments and beads, and they were the very first artists, with Neanderthal cave art (and symbolism) in Spain apparently predating the earliest modern human art by some 20,000 years. They are thought to have hunted on land and done some fishing. However, they went extinct around 40,000 years ago following the success of Homo sapiens in Europe.
